|
Krognes Steve E. (0001666236) |
|
|
|
Mailing Address
863 MITTEN ROAD, SUITE 102
BURLINGAME CA 94010
|
|
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)
|
|
Items 1 - 80
The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.
| D |
2025-02-28 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2469.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2025-02-28 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
10528.0000 |
1 |
0001576280 |
Common Stock |
| D |
2025-01-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2623.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2025-01-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
10374.0000 |
1 |
0001576280 |
Common Stock |
| D |
2025-01-07 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
3339.0000 |
25757.0000 |
1 |
0001714899 |
Common Stock |
| D |
2024-12-31 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
30000.0000 |
29096.0000 |
1 |
0001714899 |
Common Stock |
| D |
2024-12-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
2777.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-12-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
10220.0000 |
1 |
0001576280 |
Common Stock |
| A |
2024-11-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
10065.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-11-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2932.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-10-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
9911.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-10-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3086.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-09-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
9757.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-09-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3240.0000 |
2 |
0001576280 |
Restricted Stock Units |
| D |
2024-09-30 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
30000.0000 |
29096.0000 |
1 |
0001714899 |
Common Stock |
| A |
2024-08-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
9603.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-08-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
3394.0000 |
2 |
0001576280 |
Restricted Stock Units |
| D |
2024-08-20 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
1727.0000 |
32677.0000 |
1 |
0001714899 |
Common Stock |
| A |
2024-07-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
9448.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-07-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3549.0000 |
2 |
0001576280 |
Restricted Stock Units |
| D |
2024-07-01 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
29900.0000 |
34504.0000 |
2 |
0001714899 |
Common Stock |
| D |
2024-07-01 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
100.0000 |
34404.0000 |
3 |
0001714899 |
Common Stock |
| A |
2024-06-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
9294.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-06-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3703.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-06-13 |
|
PLIANT THERAPEUTICS, INC. |
4 |
A-Award |
--D |
53528.0000 |
53528.0000 |
1 |
0001746473 |
Common Stock (Right to Buy) |
| D |
2024-06-13 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
688.0000 |
52620.0000 |
1 |
0001714899 |
Common Stock |
| A |
2024-06-12 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
5592.0000 |
9140.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-06-12 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
5592.0000 |
0.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-06-12 |
|
Guardant Health, Inc. |
4 |
A-Award |
--D |
10703.0000 |
10703.0000 |
3 |
0001576280 |
Stock Option (Right to Buy) |
| A |
2024-06-12 |
|
Guardant Health, Inc. |
4 |
A-Award |
--D |
6674.0000 |
6674.0000 |
4 |
0001576280 |
Restricted Stock Units |
| A |
2024-05-31 |
|
Denali Therapeutics Inc. |
4 |
A-Award |
--D |
17901.0000 |
17901.0000 |
3 |
0001714899 |
Stock Option (right to buy) |
| A |
2024-05-31 |
|
Denali Therapeutics Inc. |
4 |
A-Award |
--D |
5967.0000 |
53308.0000 |
1 |
0001714899 |
Common Stock |
| D |
2024-05-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
3857.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-05-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
3548.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-04-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
4012.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-04-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3393.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-04-01 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
92500.0000 |
47341.0000 |
1 |
0001714899 |
Common Stock |
| A |
2024-03-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3239.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-03-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
4166.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-02-29 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
3085.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-02-29 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
4320.0000 |
2 |
0001576280 |
Restricted Stock Units |
| D |
2024-02-13 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
2750.0000 |
139841.0000 |
1 |
0001714899 |
Common Stock |
| D |
2024-01-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
4474.0000 |
2 |
0001576280 |
Restricted Stock Units |
| A |
2024-01-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
2931.0000 |
1 |
0001576280 |
Common Stock |
| D |
2024-01-05 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
3208.0000 |
142591.0000 |
1 |
0001714899 |
Common Stock |
| A |
2023-12-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2776.0000 |
1 |
0001576280 |
COMMON STOCK |
| D |
2023-12-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
4629.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-11-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2622.0000 |
1 |
0001576280 |
COMMON STOCK |
| D |
2023-11-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
4783.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-10-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2468.0000 |
1 |
0001576280 |
COMMON STOCK |
| D |
2023-10-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
4937.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-09-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
2314.0000 |
1 |
0001576280 |
COMMON STOCK |
| D |
2023-09-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
155.0000 |
5091.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| D |
2023-08-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
5246.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-08-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2159.0000 |
1 |
0001576280 |
COMMON STOCK |
| D |
2023-08-21 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
1419.0000 |
145799.0000 |
1 |
0001714899 |
Common Stock |
| D |
2023-07-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
5400.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-07-31 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
154.0000 |
2005.0000 |
1 |
0001576280 |
COMMON STOCK |
| D |
2023-06-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
1851.0000 |
5554.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-06-30 |
|
Guardant Health, Inc. |
4 |
M-Exempt |
--D |
1851.0000 |
1851.0000 |
1 |
0001576280 |
COMMON STOCK |
| A |
2023-06-16 |
|
Gritstone bio, Inc. |
4 |
A-Award |
--D |
51800.0000 |
51800.0000 |
1 |
0001656634 |
Stock Option (Right to Buy) |
| A |
2023-06-14 |
|
Guardant Health, Inc. |
4 |
A-Award |
--D |
5592.0000 |
5592.0000 |
2 |
0001576280 |
RESTRICTED STOCK UNITS |
| A |
2023-06-14 |
|
Guardant Health, Inc. |
4 |
A-Award |
--D |
8803.0000 |
8803.0000 |
1 |
0001576280 |
STOCK OPTION (RIGHT TO BUY) |
| A |
2023-06-01 |
|
Denali Therapeutics Inc. |
4 |
A-Award |
--D |
12649.0000 |
12649.0000 |
3 |
0001714899 |
Stock Option (right to buy) |
| A |
2023-06-01 |
|
Denali Therapeutics Inc. |
4 |
A-Award |
--D |
4216.0000 |
147218.0000 |
1 |
0001714899 |
Common Stock |
| D |
2023-02-13 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
2119.0000 |
143002.0000 |
1 |
0001714899 |
Common Stock |
| D |
2023-02-08 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
1377.0000 |
145121.0000 |
1 |
0001714899 |
Common Stock |
| D |
2023-01-05 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
2970.0000 |
146498.0000 |
1 |
0001714899 |
Common Stock |
| D |
2022-08-19 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
2253.0000 |
149468.0000 |
1 |
0001714899 |
Common Stock |
| A |
2022-08-09 |
|
Guardant Health, Inc. |
4 |
A-Award |
--D |
11879.0000 |
11879.0000 |
2 |
0001576280 |
STOCK OPTION (RIGHT TO BUY) |
| A |
2022-08-09 |
|
Guardant Health, Inc. |
4 |
A-Award |
--D |
7405.0000 |
7405.0000 |
1 |
0001576280 |
RESTRICTED STOCK UNITS |
| D |
2022-07-19 |
|
Denali Therapeutics Inc. |
4 |
M-Exempt |
--D |
62500.0000 |
0.0000 |
3 |
0001714899 |
Stock Option (right to buy) |
| A |
2022-07-19 |
|
Denali Therapeutics Inc. |
4 |
M-Exempt |
--D |
62500.0000 |
151721.0000 |
1 |
0001714899 |
Common Stock |
| A |
2022-06-17 |
|
Gritstone bio, Inc. |
4 |
A-Award |
--D |
19000.0000 |
19000.0000 |
1 |
0001656634 |
Stock Option (Right to Buy) |
| D |
2022-02-11 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
2560.0000 |
120221.0000 |
1 |
0001714899 |
Common Stock |
| D |
2022-02-09 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
1296.0000 |
122781.0000 |
1 |
0001714899 |
Common Stock |
| D |
2022-01-05 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
2225.0000 |
124077.0000 |
1 |
0001714899 |
Common Stock |
| A |
2022-01-03 |
|
Denali Therapeutics Inc. |
4 |
A-Award |
--D |
31000.0000 |
126302.0000 |
1 |
0001714899 |
Common Stock |
| A |
2022-01-03 |
|
Denali Therapeutics Inc. |
4 |
A-Award |
--D |
93000.0000 |
93000.0000 |
3 |
0001714899 |
Stock Option (right to buy) |
| D |
2021-08-19 |
|
Denali Therapeutics Inc. |
4 |
S-Sale |
--D |
200.0000 |
95302.0000 |
2 |
0001714899 |
Common Stock |
http://www.sec.gov/cgi-bin/own-disp
